1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsThis program aims to identify and support innovative projects with strong scientific, medical, and economic potential in advanced therapies and genetic medicine. It facilitates access to scientific, regulatory, industrial, and entrepreneurial expertise.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →According to the current listing, eligibility includes: Startups and SMEs with a target project maturity of TRL 3-7. Confirm the full requirements in the official notice before applying.
The current listing shows up to €300,000 (in the form of specialized services). Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was September 15, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Genetic Medicine Incubation and Acceleration Program (GenoTher) is funded by France 2030 initiative (managed by GenoTher). Verify program details on the funder's official page before applying.
Past winners and funding trends for this program
Preclinical Development (PDEV) program is sponsored by California Institute for Regenerative Medicine (CIRM). The PDEV program supports preclinical development of stem cell-based and genetic therapies that offer potential for transformative clinical impact and address current barriers to patient access. This includes research on stem cell-derived retinal pigment epithelium (RPE) cells for treating maculopathies and supporting photoreceptors.
CLIN2 Awards: Funding Opportunity for Clinical Trials is sponsored by California Institute for Regenerative Medicine (CIRM). CIRM's CLIN2 Awards program supports the clinical development of stem cell-based and genetic therapy approaches for treating diseases with unmet medical needs. The program aims to expedite clinical development towards late-stage trials through innovative trial designs and strategies for market access and pre-commercialization.